Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subjects: Conference, Webcast

ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference


ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organization, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 5:15pm PST/8.15pm EST.

Any changes to these events and links to the live webcasts (where available) will be posted on the Investor section of our website under "Events".

About ICON plc

ICON plc is a world-leading healthcare intelligence and clinical research organization. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 41,150 employees in 106 locations in 53 countries as at September 30, 2023. For further information about ICON, visit: www.iconplc.com.

This press release contains forward-looking statements. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. These statements are not guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. The forward-looking statements are subject to future events, risks, uncertainties and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the opening of new offices and offering of new services, the integration of new business mergers and acquisitions, the impact of COVID-19 on our business, as well as other economic and global market conditions and other risks and uncertainties detailed from time to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should not place undue reliance on these forward-looking statements when making investment decisions. The word "expected" and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are only as of the date they are made and we do not undertake any obligation to update publicly any forward-looking statement, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by ICON, including its Form 20-F, F-1, F-4, S-8, F-3 and certain other reports, which are available on the SEC's website at http://www.sec.gov.

ICON/ICLR-G


These press releases may also interest you

at 04:15
Fastest Labs Announces Expansion into Coastal North Carolina
Fastest Labs, a leading national drug, alcohol, and DNA testing company, is expanding its presence in North Carolina with a new franchise location in Wilmington, NC. The move marks a significant stride in the company's efforts to provide fast,...

at 04:15
New multi-stakeholder industry initiative launched in the UK to take collaborative action on recycling of primary pharmaceutical packaging
The Circularity in Primary Pharmaceutical Packaging Accelerator (CiPPPA) initiative launched this week to tackle the challenges of recycling medicinal devices and pharmaceutical packaging. The pharmaceutical industry faces recycling difficulties due...

at 04:06
Resource-Appropriate Cancer Care, Including Coexisting Health Issues of HIV and Cancer, to be Addressed During Meeting in Nairobi
Local and global experts are meeting in Nairobi, Kenya to update clinical practice guidelines as part of ongoing work with Allied Against Cancer?a collaboration between the National Comprehensive Cancer Network® (NCCN®), African...

at 04:00
Ellipses' next generation selective RET inhibitor EP0031/A400 cleared to start Phase 2
Ellipses Pharma Limited ("Ellipses"), a global drug development company focused on accelerating the development of cancer treatments through an innovative drug development model, announced today the U.S. Food and Drug Administration (FDA) has...

at 02:30
Pop-R&B Artist & International Award-Winning Classical Pianist Janet Noh Releases Critically Acclaimed 'Oh Child' Record and Film Production. 100% of Proceeds Are Being Donated to the Korean American Family Service Center, Supporting Survivors of Domestic Abuse.
On April 30th, 2024, in celebration of Mental Health Awareness Month and AAPI Heritage Month,  international award-winning classical pianist and pop-R&B singer Janet Noh released her newest record 'Oh Child' as well as its accompanying cinematic...

at 02:05
Epsilogen Appoints Ashley Nagle as Chief Business Officer and Peter Finan as Non-Executive Chairman as Part of Broader Company Expansion
Epsilogen, a global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer, today announces the appointments of Ashley Nagle as Chief Business Officer (CBO) and Peter Finan, currently a Non-Executive Director, as Non-Executive...

More news about Health...


News published on and distributed by: